Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950103-25-000590
Filing Date
2025-01-16
Accepted
2025-01-16 17:15:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A dp223541_defa14a.htm DEFA14A 66305
  Complete submission text file 0000950103-25-000590.txt   67294
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39329 | Film No.: 25536388
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)